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ABSTRACT 
An understanding of the normal aging process across the lifespan is important for gaining 
an understanding the pathophysiological changes that occur in accelerated aging diseases, such as 
Alzheimer’s Disease Dementia (ADD) and Vascular Dementia (VaD). The present study cross-
sectionally analyzed cortical thickness values derived from T1-weighted magnetic resonance 
images from two large cohorts: The Human Connectome Project and the Mayo Clinic Study of 
Aging. The 897 participants aged between 22-36 from the Human Connectome Project and the 
801 participants aged between 52-92 from the Mayo Clinic Study of Aging created a robust cohort 
of non-demented individuals across the lifespan. We found age effects in four out of five composite 
regions of interest (Sensorimotor Cortex, Parietal Lobe, Frontal Lobe, and Cingulate Gyrus) in 
both cohorts. As expected, the age effects were more significant in older individuals from the 
Mayo Clinic Study of Aging. There were additionally sex effects within the Mayo Clinic Study of 
Aging cohort, but not in the Human Connectome Project. By showing significant sex effects within 
older individuals but not in younger individuals, there is likely a point beyond age 36 in which 
there exists a transitional period that sparks future sex-specific decline.  
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 INTRODUCTION 
In order to understand the pathophysiological changes underlying dementia, it is first 
necessary to understand the normal aging process. By understanding the brains of those who aging 
normally and do not have dementia, perhaps we can better understand the risk factors of dementia. 
The purpose of this study is to elucidate the cortical thickness changes that occur in non-demented 
individuals throughout the life span. 
Throughout the field of MRI data analysis and epidemiological research as a whole, a major 
driver for statistical power is the creation of cohorts containing many participants. As it is often 
difficult to obtain large cohorts of non-demented individuals from a single institution, and, with 
an understanding of the importance of generating a large cohort from which generalizations can 
be made, the present study seeks to combine sample populations from the Human Connectome 
Project Phase 1a/1b and Mayo Clinic Study of Aging. The resulting cohort identifies 1,698 
individuals aged between 22 and 92 years of age. The generation of a robust cohort of non-
demented individuals cross the life span allows for an understanding of the cortical thinning 
patterns that occur throughout life. An understanding of the morphological changes in the brains 
on non-demented individuals provides insight into normal aging and could provide an 
understanding of who some transition to accelerated aging pathologies. Identifying cortical 
thinning changes across a clinically normal cohort throughout the lifespan could allow for future 
studies to elucidate the contribution from other risk factors of dementia, such as cardiovascular 
and metabolic disease. 
Human Connectome Project and the Mayo Clinic Study of Aging 
 
The first cohort of interest is from The Human Connectome Project (HCP), which is a 
consortium, led by Washington University in St. Louis, University of Minnesota, and Oxford 
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University. Its goal is to elucidate macroscopic human brain connectivity maps using advanced 
non-invasive imaging techniques. Participants of the HCP underwent a total of 4 imaging session 
of 1 hour intervals so that researchers could acquire data for four imaging modalities: structural 
MR images (T1 weighted and T2 weighted), resting-state fMRI, task-evoked fRMI, and diffusion 
imaging (dMRI) images (Van Essen et al., 2013). The pilot project (also known as Phase 1a/1b) 
for the HCP, which began in 2010, sought to enroll 1200 healthy adults with ages ranging from 
22-36. Subjects were scanned at Washington University in St. Louis with a 3 Tesla (3T) scanner 
that was specially designed to have higher temporal resolution than standard scanners of the time. 
One of the primary goals of the HCP is to amass a wealth of unprocessed and minimally processed 
MRI data and to make these data freely available to investigators. The objective of releasing public 
data is rooted in the promotion of scientific discovery for individuals who would not normally 
have access to such advanced data.  
The second cohort of interest is the Mayo Clinic Study of Aging (MCSA). The MCSA is 
an epidemiological study of the prevalence, incidence, and risk factors of Mild Cognitive 
Impairment (MCI) and dementia among Olmsted Country, MN residents. This study was 
enumerated by the Rochester Epidemiological Project (REP), which sought to establish a 
population-based cohort of individuals aged 70+ (Roberts et al., 2008). Olmsted County is 
unusually suitable for this project, as most residents seek care from two providers, either the Mayo 
Clinic or Olmsted Medical Center. Because Olmsted Country residents were heavily concentrated 
between these two providers, medical records systems could be easily linked. The REP established 
this linkage of medical records systems and allowed researchers to generate a comprehensive list 
of all residents within the county (Melton, 1996). From this comprehensive list of Olmsted County 
residents, Mayo Clinic researchers are able to accurately evaluate risk factors of MCI and dementia 
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for a community-dwelling population. The MCSA is one of the largest and oldest running studies 
of aging. It has enrolled around 3,000 individuals to date and much research is dedicated towards 
the elucidation of biomarkers of Alzheimer’s disease and other dementias, in the hope of the 
creation of interventions to ameliorate potential symptoms before they arise. While focusing on 
Olmsted County, the Mayo Clinic Study of Aging minimizes sample biases, which increases the 
generalizability of results. Though, Olmsted County is predominantly Caucasian, meaning there is 
the possibility for confounding factors, arising as a result of differences in ethnic background, 
socioeconomic status, and education levels, to name a few, which can have profound effects in 
epidemiological studies (Machulda et al., 2013).  
By combining cohorts from different institutions, not only does statistical power increase 
as a result of the increased number of participants, but researchers are able to better capture the 
subtleties of communities that could be lost in homogenous populations.  
Background 
 
In the period between 2012 and 2050, the Unites States is expected to undergo rapid growth 
within the older population (65 and above). By 2050, the number of older individuals is expected 
to reach 83.7 million (Ortman, Velkoff & Hogan, 2014). This dramatic increase in the older 
population will likely result in higher incidence and prevalence of neurodegenerative disorders. 
Because age is the greatest risk factor for neurodegenerative disease, it is important to not only 
understand the process of normal aging but also factors that could contribute to the exacerbation 
of aging pathology (Fjell et al., 2014).  
As the proportion of older individuals increases within the United States, it is additionally 
expected that drivers of mortality will also change (Ortman, Velkoff & Hogan, 2014). Whereas 
drivers of mortality among older individuals was typically seen as most commonly due to 
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complications from either smoking or obesity, it is possible that this dynamic could change over 
time.  Ongoing campaigns aimed at reducing the likelihood of younger individuals exposed to 
cigarettes is likely to reduce smoking as a contributor of mortality over time. Conversely, rates of 
obesity have steadily increased. In fact, between 1980 and 2008, incidence of obesity has doubled 
in adults and has tripled in children (Centers for Disease Control and Prevention, 2011). Obesity 
can directly increase the risk of other health conditions, including hypertension, lipid imbalances, 
and type II diabetes (Ogden et al., 2012). The discussion of obesity and its related health risks is 
relevant to neurodegenerative disease due to literature noting the linkage between cardiovascular 
disease and the onset of dementia in older adults (Snyder et al., 2015; Geda et al., 2010; Marchant, 
Reed, & Sanossian et al., 2013; Krell-Roesch et al., 2017). Troublingly, the U.S. Census Bureau 
has yet to address to the effect of age-related cognitive decline and its contribution to changes in 
mortality. The issue becomes more complicated given that some with Alzheimer’s disease 
dementia go undiagnosed, deaths due to Alzheimer’s disease dementia are under reported, and it 
is possible that ADD can complicate other diseases or causes of death. 
Given the expected increase in the older population and increases in obesity and related 
cardiovascular and metabolic disease, it necessary that researchers seek an understanding of the 
pathological progression of cardiovascular and metabolic disease with respect to the incidence and 
prevalence of neurodegenerative disease. In order to do so, one must understand the progression 
of normal aging to provide a baseline level against which additional pathologies (such as those 
arising from cardiovascular or metabolic disease) could arise. However, it is first necessary to 
understand (i) why aging is a risk-factor for dementia in later life and (ii) what morphological brain 
changes that occur within non-demented individuals.  
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In an attempt to address these issues, the present study seeks to investigate morphological 
changes that occur as non-demented individuals age. It does so by examining cortical thickness 
values in individuals aged between 22 and 92 years of age. Because measures of brain atrophy –  
for which cortical thickness is a measure – are strongly correlated to the severity of cognitive 
impairment, and because the rate of brain atrophy is correlated with rates of cognitive decline, the 
rate of brain atrophy is correlated with the rate of cognitive decline (Jack et al., 1992; Fox, Scahill, 
Crum, and Rossor, 1999; Jack et al., 2010). By cross-sectionally investigating cortical thickness 
across the lifespan in a clinically normal, non-demented population, the present study provides an 
understanding of cognitive decline that is attributable to the normal aging process.  
Normal Aging 
 
Aging is associated with significant morphological- and functional-related brain changes, 
which can result in dementia. These changes are reflected in observations of age-related decline in 
cognitively demanding tasks, such as declines in mental speed (Salthouse, 1996), executive 
functioning (Rabbitt et al., 2001), and episodic memory (Buckner, 2004).  Normal aging is defined 
as cognitive decline that is attributable to one’s age and level of formal education, as cognitive 
decline is expected in all individuals (Peterson et al., 1992). 
Dementia  
 
Dementia is a progressive neurodegenerative disease in which an individual is experiencing 
a level of cognitive decline that is worse than expected. As such, a diagnosis of dementia arises 
when individuals age more quickly than others of their same age and level of formal education 
(Jack et al., 1992). 
Alzheimer’s disease dementia (ADD) is the most common cause of dementia and the sixth 
most common cause of death among older individuals (Alzheimer’s Disease Fact Sheet, 2017). 
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The pathology of ADD has been classically characterized with the appearance of (i) extracellular 
depositions of amyloid-ß (plaques), (ii) the intracellular accumulation of the microtubule 
associated protein, tau (tangles), and (iii) global atrophy of brain tissue (Jack et al., 2011). Ongoing 
research has identified a number of other pathological changes that occur within individuals with 
ADD, such as the appearance of alpha-synuclein, abnormalities of TDP-43, increased free radical 
production due to dysfunctional mitochondria, and increases in pro-inflammatory cytokines 
(Majbour et al., 2017; Niblock et al., 2016; Angelova & Abramov. 2017; Prasad, 2016; Regen, 
Hellmann-Regen, Costantini, & Reale. 2017). Taken together, these pathological changes 
emphasize the role of the neuroinflammatory response, glucose metabolism, as well as energy 
processing more generally (Kanvah and Schuster, 2005).  
It is currently believed that around 5 million Americans have ADD (Alzheimer’s Disease 
Fact Sheet, 2017). This number is expected to rise dramatically given the increases population of 
older individuals coupled with increased levels of obesity and related cardiovascular disease. 
Estimates predict that by 2050, prevalence of AD will increase to 1 in 85 individuals (Rocca et al., 
2011). Additionally, there is a higher frequency of ADD dementia among females compared to 
males (Mielke, Vemuri, & Rocca 2014). 
Vascular dementia (VaD) is the second most common cause of dementia among older 
individuals. Symptoms between AD and VaD are similar, and it is often difficult to differentiate 
between the two without MRI analysis. VaD is the result of vascular disease within the brain. As 
individuals age, cholesterol and other substances accumulate in blood vessel walls, which results 
in the thickening and hardening of these walls. In turn, blood flow is either reduced or stopped 
entirely. The complete stop of blood flow throughout certain parts of the brain (ischemia) results 
in an infarction, or necrosis of tissue due to hypoxia (Thal., Grinberg, & Attems, 2012). These 
CORTICAL THICKNESS ACROSS THE LIFESPAN 
 11 
infarctions can vary in seriousness depending on the amount of time areas of the brain are without 
the necessary oxygen. Current understanding of VaD posits that the cumulative necrosis as a result 
of many silent cerebral infarctions (silent strokes) accounts for the cognitive deficits seen in older 
individuals suspected of having VaD (Mayo Clinic, 2014).  
Importance of imaging data in dementia research 
 
As it is often difficult to determine whether an individual has dementia through 
neurological exams, measures of cognitive performance, and medical history alone, it is necessary 
to investigate neural tissue in order to determine if there exist clues of accelerated aging 
pathologies. Diagnostic radiologists and researchers studying dementia rely on magnetic 
resonance imaging (MRI) to non-invasively visualize brain areas related to dementia.  
Structural MRI provides both qualitative and quantitative representation of gray and white 
matter structures. Gray matter can be thought of as areas of the brain in which there is an abundance 
of neuronal cell bodies or glial cells. In contrast, white matter areas are primarily composed of 
sections of myelinated axons. Depending on the type of neural tissue researchers are interested in, 
it is possible to adjust sequences of the scanner to maximize the visualization capabilities. 
Changing the sequence parameters of repetition time (TR) and echo time (TE) can be used to 
emphasize differences between gray and white matter within images. The two types of images 
derived from structural MRI scans are known as T1-weighted and T2-weighted images. 
T1-weighted images are used because of their high degree of contrast between gray matter 
(appearing dark gray), white matter (appearing as a lighter gray), and cerebral spinal fluid, which 
is void of signal and appears black. T1-weighted images are produced by establishing a short 
retention time and a short echo time. The resulting image allows for maximal contrast between 
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neocortical gray matter and white matter; though, contrast between subcortical gray and white 
matter is reduced.  
 T2-weighed images are typically used when one is interested in the white matter integrity 
of an individual. They are the result of a long retention time and a long echo time. Resulting images 
show CSF as bright and brain tissue shown in gray. Gray matter is seen in a lighter gray, whereas 
white matter is shown in a darker gray color. Because polar solutions, such as water and CSF 
appear dark, they can be easily differentiated from fatty structures, such as the myelin sheath of 
axons.  
Together, both T1- and T2-weighted images allow noninvasive measures of architectural 
properties such as myelin content within the cerebral cortex and cortical thickness that recapitulate 
with corresponding invasive measures (Glasser et al., 2016; Fischl, 2000; Glasser et al., 2014; 
Glasser & Van Essen, 2011).  
Within the context of research, the type of scan analyzed is determined by the cohort of 
individuals one is seeking to study. Typically, cortical thickness data, derived by T1-weighted 
Figure 1 Comparison of diffusion weighted images: T1-weighted, T2-weighted, and Flair images 
(Preston, 2006)  
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images, are used when researchers are interested in individuals who are non-demented and are 
aging normally. T1-weighed images would not be suitable for accelerated pathological aging or 
for diseases of white matter because of the low contrast that exists in T1-weighted images between 
subcortical gray and white matter. If one were interested in severe dementia or white matter 
diseases, volume data, derived from T2-weighted images, would be preferred. These T2-weighted 
images would provide adequate contrast between white and gray matter structures and allow for 
the elucidated of the integrity of white matter tracts.  
In epidemiological research, cortical thickness measurements are preferred for studies 
using non-demented individuals because it is the best measurement for separating individuals 
based on diagnoses. This means that differences in T1-weighted scans between non-demented and 
demented individuals is most obvious. Additionally, T1-weighted images are less likely to be 
confounded by total intracranial volume (TIV), unlike volumetric measurements (Schwartz, 2016). 
Taken together, it is clear that for investigations regarding the structural integrity of gray matter 
within non-demented individuals, T1-weighted images should be used. Further, the usage of 
cortical thickness data is best-suited for research, as it has less potential to be confounded.  
Sex differences in cortical thickness and cardiovascular/metabolic diseases 
 
There exists growing interest in understanding the morphological changes that occur in the 
normal aging process. Researchers are further interested in determining whether there exist sex 
differences in non-demented individuals. While there is established literature supporting sex 
differences in cognitive performance – i.e. a male advantage in spatial abilities (Kimura, 2000) 
and a female advantage in verbal memory tasks and speed of articulation (Sommer, Aleman, 
Bouma, & Kahn, 2004) – the identification of the morphological underpinnings of these 
advantages and their relationship to the normal aging processes remains unknown. Indeed, the 
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current literature is conflicting. Some studies have noted differences between the sexes (Chung et 
al., 2006; Cowell et al., 1994; Good et al., 2001; R. C. Gur, Gunning-Dixon, Bilker, & Gur, 2002; 
Murphy, DeCarli, Mclntosh, & al, 1996; Pruessner, Collins, Pruessner, & Evans, 2001; Raz, 
Rodrigue, Head, Kennedy, & Acker, 2004; Riello et al., 2005; Scahill et al., 2003; Sowell et al., 
2007); (Arani et al., 2015; Gong et al., 2009; Hazlett et al., 2010; Jiang et al., 2014; Liu et al., 
2011; Nunnemann et al., 2009; Sundermann et al., 2016); while others have not (Fjell et al., 2012; 
Greenberg et al., 2008; Lemaitre et al., 2005; Salat et al., 2004).  
Additionally, there are also established differences in cardiovascular and metabolic disease 
profiles between the sexes. Notably, it has been hypothesized that women experience a lower 
cardiovascular risk than men (Mosca et al., 2004). This lower cardiovascular risk culminates the 
effect of common disorders, such as obesity, type II diabetes, and hypertension. Though, it is 
unknown how these differences effect the potential for cortical thinning.  
Sample Sizes & Cohort Consolidation 
 
Because the goal of epidemiological studies is to provide generalizable results that 
correspond to larger patient populations, it is paramount that cohort sizes are maximized. A 
common technique to maximize cohort sizes is to combine datasets between research groups and 
institutions. There are, however, a number of factors that could confound results to produce an 
unreliable data set, from which it would be inappropriate to extrapolate. In order to facilitate the 
combination of cohorts, it is preferred that the cohorts mirror one another in multiple categories. 
Of major importance are the usage of similar: statistical analyses, demarcation for ROI, image 
quality, segmentation procedures, and sample characteristics (Fjell et al., 2009). These factors will 
be discussed in greater detail later.  
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Objective 
 
The purpose of this study is to investigate cortical thickness changes that occur in non-
demented individuals throughout the life span. To do so, we will combine sample populations from 
the Human Connectome Project Phase 1a/1b and Mayo Clinic Study of Aging to create a robust 
cohort of 1,698 non-demented individuals aged between 26 and 92 years of age.  
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METHODS 
Sample Populations 
 
The Human Connectome Project Phase 1a/1b 1200 subjects project identified 970 
participants. Of these participants, 897 participants, aged between 22 and 36, completed the MRI 
battery, which included Diffusion Imaging (T1 and T2 weighted imaged), Resting-state fMRI and 
Task-fRMI. Participants of the Human Connectome Project were subject to a wide array of 
behavioral measures. These measures were conducted on both on the computer and with self-
reported pen-and-paper tests. The computer tests, as part of the NIH toolbox included testing the 
“domains of cognition (verbal IQ, working memory, executive function, attention, language, and 
processing speed), emotion (negative affect, positive affect, stress and coping, and social 
relationships), motor function (locomotion, dexterity, strength, and endurance), and sensation 
(hearing, taste, touch, and smell)” (Van Essen et al., 2012). The broad behavioral tests employed 
Figure 2 Schematic summary of behavioral testing procedure, and MR, MEG, and EEG scanning 
procedure for the Human Connectome Project  (Van Essen et al., 2012). 
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by the Human Connectome Project was done intentionally in order to produce large amounts of 
data to facilitate many comparative studies in the future.  
 The Mayo Clinic Study of Aging identified 801 older participants, aged between 51-92 
years old, for analysis. Participants in the Mayo Clinic Study of Aging underwent a 
neuropsychological battery of nine tests, described in previous work (Roberts, 2008), which was 
used to assess four cognitive domains. The domains evaluated were (i) executive functioning (Trail 
Making Test Part B, Wechsler Adult Intelligence Scale-R Digit Symbol), (ii) language (Boston 
Naming Test, category fluency), (iii) memory (Wechsler Memory Scale-R Logical Memory-II, 
Wechsler Memory Scale -R Visual Reproduction II, Rey Auditory Verbal Learning Test, delayed 
recall), and (iv) visuospatial performance (Wechsler Adult Intelligence Scale-R Picture 
Completion, Wechsler Adult Intelligence Scale-R Block Design).  
Figure 3 Flow chart of the protocol of the Mayo Clinic Study of Aging, from initial blood draws 
and clinical evaluations to neuropsychological battery (Roberts et al., 2008) 
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Sample Characteristics 
Table 1 Demographic characteristics of Human Connectome Project and Mayo Clinic Study of 
Aging cohorts, as well as cognitive evaluations 
  Female N=885 Male N=813 
		 Age N MMSE Age N MMSE 
Human 
Connectome 
Project 
N=897 
22-25 73 28.88 ± 1.09 22-25 111 28.81 ± 1.18 
26-30 222 29.10 ± 0.93 26-30 169 29.00 ± 1.08 
31-35 205 29.00 ± 1.00 31-35 111 29.06 ± 0.99 
36+ 3 29.00 ± 1.00 36+ 3 28.50 ± 1.66 
Mayo Clinic 
Study of 
Aging N=801 
50-59 34 28.82 ± 0.90 50-59 24 28.71 ± 0.91 
60-69 72 28.47 ± 1.09 60-69 105 28.54 ± 0.85 
70-79 200 28.54 ± 1.02 70-79 194 28.33 ± 1.33 
80+ 76 28.40 ± 1.13 80+ 96 27.97 ± 1.40 
 
Table 1 Legend. Mini-Mental State Examination (MMSE) scores are displayed as mean ± standard 
deviation. MMSE scored between 0-30 with higher scores denoting a lower degree of impairment 
(Folstein. Folstein, & McHugh, 1975).  
 
The characteristics of all participants are shown in Table 1. The 897 participants from the 
Human Connectome Project and the 801 participants of the Mayo Clinic Study of Aging were 
combined to create a cohort of 1,698 individuals aged between 22-92 years old. Of the 1,698 
individuals, 813 (48%) were male. As such, the proportions of men and women were well balanced 
within the combined cohort. Because the Human Connectome Project did not account for 
education level within pre-screening, it is unknown whether the two cohorts vary in level of 
education. MMSE scores, reported as mean score plus or minus the standard deviation of each age 
range, indicate no significant differences in level of impairment between any age range or between 
the sexes. Despite similar levels of cognitive performance, it is clear that there exist discrepancies 
in the proportion of individuals within each age range. Potential ramifications of these cohort 
effects will be discussed in a later section.  
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MR Acquisition & Cortical Thickness Measurement 
 
For the Human Connectome Project, T1-weighted MRI (MP-RAGE) scans were 
performed on Skyra 3T scanners manufactured by Siemens with the following specifications: 
repetition time = 2400 ms, echo time (TE) = 2.14 ms, and inversion time (TI) = 1000 ms; voxel 
dimensions were 0.7 mm isotropic. The HCP calculated cortical thickness using the minimal 
preprocessing pipeline from FreeSurfer, which encapsulates PreFreeSurfer, FreeSurfer, and 
PostFreeSurfer. 
For the Mayo Clinic Study of Aging cohort, T1-weighted MRI (MP-RAGE) scans were 
performed on 3T scanners (models Discovery MR750, Signa Excite, Signa HDx, Signa HDxt) 
manufactured by General Electric (GE) with the following specifications: repetition time was 
≈2300 ms, echo time (TE) ≈ 3 ms, and inversion time (TI) = 900 ms; voxel dimensions were ≈ 
1.20 × 1.015 × 1.015 mm. Cortical thickness values were computed using the DiReCT algorithm 
(Das & Sandhitsu, 2009) in combination with tissue segmentations by SPM12 (Ashburner, 2005).   
Regions of Interest (ROI) 
 
For both cohorts, seven composite anatomically defined regions of interests were generated 
by computing average thicknesses derived from the greater dataset. The medial temporal lobe was 
excluded from subsequent analyses, as this region was highly correlated with intracranial volume 
due to the sulcal folding of subcortical structures such as the hippocampus. To minimize the 
number of comparisons, averages of the remaining six ROI (temporal lobe, cingulate gyrus, 
parietal lobe, frontal lobe, occipital lobe, and sensorimotor cortex) were calculated and 
subsequently analyzed.  
Statistical Analyses 
 
All analyses were performed using MATLAB (MathWorks Inc., Natick, MA). Scatter plots 
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of cortical thickness data for six anatomically defined regions of interest were created versus age, 
dichotomized by sex. Generalized linear regression models were run to test the relationship 
between age and cortical thickness dichotomized by sex and by region of interest. Analysis of 
Covariance (ANCOVA) and Analysis of Variance (ANOVA) were subsequently performed to 
compare the cortical thinning patterns between men and women for the combined HCP + MCSA 
cohort. 
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RESULTS 
Sample Characteristics 
 
The participant characteristics are shown in Table 1. The proportion of men and women 
were well balanced in the combined cohort. There were no significant differences in cognitive 
performance, according to MMSE scores between age ranges and between the sexes. Due to 
differences in neuropsychological testing, there existed few characteristics that were present within 
both studies. As such, comparison of cognitive performance was limited to the MMSE. Despite 
the presence of a well-balanced cohort between the sexes, dichotomization by age group showed 
clear discrepancies in number, the potential ramifications of which will be described elsewhere.  
Linear regression results 
 
Figures 3-12 show the cortical thinning patterns in all ROI with linear regression lines. 
Analysis of Covariance (ANCOVA) and Analysis of Variance (ANOVA) were performed to 
examine age, sex, and age x sex effects.  
In the temporal lobe, there existed significant sex effects (F=4.24, p<0.05) within the 
Human Connectome Project cohort, with no significant age (F=3.77, p=0.53) or age x sex effects 
(F=0.74, p=0.39). Within the Mayo Clinic Study of Aging, analyses showed significant sex 
(F=20.62) and age (F=138.21) effects (p<0.0001) but no significant age x sex interactions (F=0.07, 
p=0.7933). 
Within the sensorimotor cortex, the younger cohort exhibited no significant sex effects 
(F=0.43, p=0.51) or age x sex effects (F=0.06, p=0.80); though, there did exist significant age 
effects (F=17.58, p<0.0001). Within the older cohort, there existed significant sex (F=17.97) and 
age (F=353.89) effects (p<0.0001) but no significant age x sex interactions (F=1.83, p=0.18) 
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Younger participants in the Human Connectome Project cohort showed no significant sex 
effects within the parietal lobe (F=1.55, p=0.21) or age x sex effects (F=0.87, p=0.35); while 
showing significant age effects (F=6.78, p=0.0094). Older participants in the Mayo Clinic Study 
of Aging cohort showed significant sex (F=15.79, p=0.001) and age effects (F=60.49, p<0.0001) 
but no significant age x sex interactions (F=0.06, p=0.80)  
Within the frontal lobe, the Human Connectome Project cohort exhibited no significant sex 
(F=1.89, p=0.17) or age x sex effects (F=2.04, p=0.15). However, younger individuals did show 
significant age effects (F=33.51, p<0.0001). In the Mayo Clinic Study of Aging, older participants 
showed significant sex (F=15.79, p=0.001) and age effects (F=60.49, p<0.0001); while showing 
no significant age x sex interactions (F=0.06, p=0.80). 
Finally, in the cingulate gyrus, younger individuals showed no significant sex effects 
(F=0.68, p=0.41) or age x sex effects (F=0.85, p=0.35); though analyses did show significant age 
effects (F=5.91, p<0.05). Older participants showed significant sex (F=7.91, p=0.005), and age 
effects (F=87.02, p<0.0001). Conversely, there did not exist significant age x sex effects (F=0.67, 
p=0.41). 
Table 2 provides a summary of results obtained from the linear regression analyses 
performed within the present study. As shown, there existed significant age effects in four out of 
the five composite regions of interest analyzed. There existed no sex x age effects in any of the 
regions between the two cohorts. Age effects were present within both the younger cohort (22-
36+) as well as in the older cohort (52-92). Unsurprisingly, age effects were more significant 
within older individuals. It is interesting to note that only the temporal lobe showed sex effects 
without age effects within the Human Connectome Project cohort.  
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Table 2 Summary of Linear Regression Analyses from both the Human Connectome Project 
cohort and the Mayo Clinic Study of Aging 
Human Connectome Project 
ROI Sex Effects Age Effects Age x Sex Effects 
Temporal Lobe yes no no 
Sensorimotor Cortex no yes no 
Parietal Lobe no yes no 
Frontal Lobe no yes no 
Cingulate Gyrus no yes no 
Mayo Clinic Study of Aging 
ROI Sex Effects Age Effects Age x Sex Effects 
Temporal Lobe yes yes no 
Sensorimotor Cortex yes yes no 
Parietal Lobe yes yes no 
Frontal Lobe yes yes no 
Cingulate Gyrus yes yes no 
 
 
 
 
 
CORTICAL THICKNESS ACROSS THE LIFESPAN 
 24 
 
 
 
 
 
24 26 28 30 32 34 36
Age
2.5
2.6
2.7
2.8
2.9
3
3.1
3.2
Co
rti
ca
l T
hic
kn
ess
2.9941*** + -0.0010749 x
3.0555*** + -0.0027165 x
Temporal Lobe
Figure 4 Temporal Lobe cortical thinning patterns for individuals aged 22-36+ from the Human Connectome 
Project cohort of 897 healthy young participants. Thickness values derived from 3T T1-weighted structural MR 
images with processing by FreeSurfer. Analysis of Covariance (ANCOVA) showed no significant delineations 
between male and female cortical thinning patterns. Analysis of Variance (ANOVA) showed significant sex 
effects (F=4.24, p<0.05); while there existed no significant age (F=3.77, p=0.53) or age x sex effects (F=0.74, 
p=0.39). 
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Figure 5 Temporal Lobe cortical thinning patterns for individuals aged 50-92 from the Mayo Clinic Study of 
Aging cohort of 801 individuals. Thickness values derived from 3T T1-weighted structural MR images with 
processing by SPM12+DiRect. Analysis of Covariance (ANCOVA) showed no significant delineations 
between male and female cortical thinning patterns. Analysis of Variance (ANOVA) showed significant sex 
(F=20.62) and age (F=138.21) effects (p<0.0001); while no significant age x sex effects were present (F=0.07, 
p=0.7933).  
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Sensorimotor Cortex
Figure 6 Sensorimotor Cortex cortical thinning patterns for individuals aged 22-36+ from the Human Connectome 
Project cohort of 897 healthy young participants. Thickness values derived from 3T T1-weighted structural MR 
images with processing by FreeSurfer. Analysis of Covariance (ANCOVA) showed no significant differences in 
cortical thinning patterns between the sexes. Analysis of Variance (ANOVA) showed no significant sex (F=0.43, 
p=0.51) or age x sex effects (F=0.06, p=0.80); though there did exist significant age effects (F=17.58, p<0.0001). 
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Sensorimotor Cortex
Figure 7 Sensorimotor Cortex cortical thinning patterns for individuals aged 50-92 from the Mayo Clinic Study 
of Aging cohort of 802 individuals. Thickness values derived from 3T T1-weighted structural MR images with 
processing by SPM12+DiRect. ANCOVA showed no significant differences in cortical thinning patterns 
between the sexes. ANOVA showed significant sex (F=17.97) and age (F=353.89) effects (p<0.0001) but no 
significant age x sex effects (F=1.83, p=0.18). 
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Figure 3 Parietal Lobe cortical thinning patterns for individuals aged 22-36+ from the Human Connectome Project 
cohort of 897  healthy young participants. Thickness values derived from 3T T1-weighted structural MR images 
with processing by FreeSurfer. ANCOVA showed no significant differences in cortical thinning patterns between 
the sexes. Analysis of Variance (ANOVA) showed no significant sex effects (F=1.55, p=0.21) or age x sex effects 
(F=0.87, p=0.35); though, there did exist significant age effects (F=6.78, p=0.0094)  
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Figure 4 Parietal Lobe cortical thinning patterns for individuals aged 50-92 from the Mayo Clinic Study of Aging 
cohort of 802 individuals. Thickness values derived from 3T T1-weighted structural MR images with processing 
by SPM12+DiRect. ANCOVA showed no significant differences in cortical thinning patterns between the sexes. 
Analysis of Variance (ANOVA) showed significant sex (F=15.79, p=0.001) and age effects (F=60.49, p<0.0001); 
while there existed no significant age x sex effects (F=0.06, p=0.80).   
 
CORTICAL THICKNESS ACROSS THE LIFESPAN 
 30 
 
24 26 28 30 32 34 36
Age
2.3
2.4
2.5
2.6
2.7
2.8
2.9
3
3.1
Co
rti
ca
l T
hic
kn
ess
2.8901*** + -0.0046369*** x
2.966*** + -0.0076308*** x
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Figure 10 Frontal Lobe cortical thinning patterns for individuals aged 22-36+ from the Human Connectome 
Project cohort of 897 healthy young participants. Thickness values derived from 3T T1-weighted structural MR 
images with processing by FreeSurfer. ANCOVA showed no significant differences in cortical thinning patterns 
between the sexes. ANOVA showed no significant sex (F=1.89, p=0.17) or age x sex effects (F=2.04, p=0.15), 
but there did exist significant age effects (F=33.51, p<0.0001).  
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Figure 5 Frontal Lobe cortical thinning patterns for individuals aged 50-92 from the Mayo Clinic Study of Aging 
cohort of 802 individuals. Thickness values derived from 3T T1-weighted structural MR images with processing 
by SPM12+DiRect. ANCOVA showed no significant differences in cortical thinning patterns between the sexes. 
ANOVA showed significant sex (F=15.79, p=0.001) and age effects (F=60.49, p<0.0001); while showing no 
significant age x sex effects (F=0.06, p=0.80).  
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Figure 12 Frontal Lobe cortical thinning patterns for individuals aged 22-36+ from the Human Connectome 
Project cohort of 897 healthy young participants. Thickness values derived from 3T T1-weighted structural MR 
images with processing by FreeSurfer. ANCOVA showed no significant differences in cortical thinning between 
the sexes. ANOVA showed no significant sex effects (F=0.68, p=0.41) or age x sex effects (F=0.85, p=0.35); 
while there did exist significant age effects (F=5.91, p<0.05).  
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Figure 6 Cingulate Gyrus cortical thinning patterns for individuals aged 50-92 from the Mayo Clinic Study of 
Aging cohort of 802 individuals. Thickness values derived from 3T T1-weighted structural MR images with 
processing by SPM12+DiRect. ANCOVA showed no significant differences in cortical thinning patterns between 
the sexes. ANOVA showed significant sex (F=7.91, p=0.005) and age effects (F=87.02, p<0.0001); though there 
did not exist significant age x sex effects (F=0.67, p=0.41).  
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DISCUSSION 
Underlying the need to understand the accelerated aging pathologies, such as Alzheimer’s 
disease dementia and Vascular dementia, researchers must first understand the morphological and 
functional changes that occur within a normally aging brain across the lifespan. The present study 
sought to elucidate morphological differences between men and women across the lifespan by 
cross-sectionally analyzing cortical thinning patterns in a combined Human Connectome Project-
Mayo Clinic Study of Aging cohort. The ultimate goal of this project was to investigate the effects 
of cardiovascular and metabolic disease between the sexes across the lifespan.  
While the present study was unable to investigate the effect of cardiovascular disease on 
cortical thinning across the lifespan as a result of imperfect compatibility between the data sets, it 
was able to investigate sex and age effects across the lifespan. The major findings of this study 
were: (i) there existed significant age effects across the lifespan in four out of five composite ROIs 
analyzed, (ii) sex effects were only present within older individuals from the Mayo Clinic Study 
of Aging cohort (52-92), but not in the younger participants (except in the temporal lobe), and (iii) 
age effects were more significant in older individuals.  
The two data sets were not perfectly compatible with one another, as the values of cortical 
thickness varied significantly between the two cohorts. Despite the inability to perform analyses 
across the lifespan about cardiovascular disease, a number of analyses were still able to be 
performed. While the analyses performed provided valuable insight into some of the processes 
underlying normal aging, it is also necessary to determine why discrepancies existed between the 
two cohorts, as the consolidation of cohorts will continue to be used to achieve large sample 
populations.  Fjell and colleagues (2009) posited that the variability arising from the consolidation 
of multiple cohorts arose due to one of more of at least 5 factors. These factors included (i) different 
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statistical analyses performed, (ii) different demarcation criteria for ROI analyses, (iii) image 
quality, (iv) different segmentation procedures, and (v) sample characteristics. Following a 
comparison of the similarities and differences between the present study and the Fjell (2009) study, 
the five potential factors that could have contributed for some of the issues arising from the attempt 
to consolidate the Human Connectome Project and Mayo Clinic Study of Aging Cohorts will be 
explored.  
Similarities and differences between present study and Fjell (2009) 
 
There were a number of analogous elements between the Human Connectome Project and 
Mayo Clinic Study of Aging processing pipelines that could contribute to the combination of the 
two cohorts to produce a single larger cohort that spanned the lifespan. The rationale behind the 
combination of the two cohorts was rooted in previous success by other groups. Notably, Fjell and 
colleagues (2009) successfully combined six cohorts from three countries and four research centers 
while using scanners that varied in both manufacturer and model. The group attributed their 
success to the usage of a “uniform semiautomated method” of measuring values of cortical 
thickness using the FreeSurfer algorithm. Researchers summarized their preference for the usage 
of FreeSurfer as follows:  
“First, they require minimal intervention by highly trained personnel 
and allow processing of many brains in a reasonable time frame. 
Second, they are characterized by very high reliability and 
repeatability of measures. Third, they allow a hypothesis-free search 
for patterns of differences without the need to define anatomically 
plausible ROIs, enabling detection of differences in regions where 
precise anatomical definitions and placement of anatomical borders 
would not be feasible” (Fjell et al., 2009). 
 
There were a number of factors which were analogous between the Fjell study and the 
present study. First, both studies utilized multi-center cortical thickness values derived from T1-
weighted MR images from both GE and Siemens scanners. As such, scanners varied in a variety 
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of MR parameters, notably, voxel size, retention time, and echo time. The analysis performed by 
Fjell and colleagues did differ from what was done in this experiment, which could have 
contributed to the different results. For example, scans performed in the Fjell analysis were 1.5T 
scans, meaning there existed a lower contrast between white and gray matter structures with which 
FreeScanner could elucidate cortical thickness values. This could be compared to the 3T scanners 
used in both the Mayo Clinic Study of Aging and the Human Connectome Project. The usage of 
3T scanners allows for both a higher signal to noise ratio, meaning 3T scans will produce a more 
accurate representation of underlying cortical networks than would a 1.5T scan.  
Further in the Fjell study, the six cohorts analyzed had participants in each cohort which 
did not vary significantly. Each cohort had similar mean ages, education levels, and similar 
IQ/MMSE scores. Contrary to the Fjell study, the present study sought to investigate across the 
lifespan using two extreme age ranges: one in early adulthood and one in the “older” years.  
Five potential factors of inconsistency  
 
(i) Statistical Analyses 
 
The present study used generalized linear models of cortical thickness values across the 
life span for both the Human Connectome Project and the Mayo Clinic Study of Aging. In neither 
case were there corrections utilized or removal of data points for any reason. By nature of the 
exploratory nature of this study and the vast amounts of secondary data that was available in both 
data sets, the present study sought to primarily look for the potential of age and sex effects across 
the lifespan between men and women. As such, it was paramount that statistical analyses were 
kept constant. It is therefore unlikely that inconsistencies in the data arose as a result of the 
statistical analyses used.  
(ii) Difference Demarcation criteria for ROI 
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By nature of the study, calculated cortical thickness values were taken from the databanks 
of the Human Connectome Project and the Mayo Clinic Study of Aging. The Human Connectome 
Project identified 34 regions of interest in both the left and right hemispheres; while the Mayo 
Clinic Study of Aging identified 43 regions of interest in each hemisphere. These regions of the 
brain are known as meta-ROIs. For both samples, it was necessary to average values of meta-ROIs 
for the left and right hemispheres to consolidate analyses. Because calculations of cortical 
thickness values were determined by respective institutions, meta-ROI differed, and the raw data 
were not available for one of the cohorts. Because of the differences in meta-ROI, it was necessary 
to consolidate them into larger “consolidated ROIs.” To do so required the consultation of a brain 
atlas to determining which region of the brain (Temporal Lobe, Sensorimotor Cortex, Parietal 
Lobe, Frontal Lobe, Cingulate Gyrus, and Medial Temporal Lobe) each meta-ROI belonged to. 
Due to the complexity of the brain and the uncertainty about how these regions of the brain interact, 
not every meta-ROI had an obvious corresponding consolidated ROI. Following the identification 
of a consolidated ROI for each meta-ROI, cortical thickness values for each of the meta-ROI were 
averaged to produce a mean cortical thickness value for the consolidated ROI for each participant. 
These individual values were then plotted and subsequently analyzed. Undoubtedly, the prescribed 
practice would inherently produce some level of uncertainty. Though, due to the nature of the data, 
this was likely the most practical and time-sensitive matter to approach the situation. While it 
would have been possible to collect the raw data of the Human Connectome Project and recalibrate 
the semi-automated procedure of FreeSurfer to produce a data set more like the Mayo Clinic data 
set, to do so would have required vast computing power and time. It is therefore possible that some 
of the inconsistencies in the data arose not only from the differential determination of meta-ROI 
but also the consolidation of these ROI. If we were to only have compared meta-ROI that were 
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present in both cohorts, the following analyses would have had large gaps within certain regions 
of the brain, which would have produced less meaningful analyses.  
(iii) Image Quality 
 
Ongoing research is investigating the accuracy and reliability of cortical thickness values 
when inherent factors differ, such as field strength, manufacturer, and pulse sequence are changed. 
While there remain unanswered questions, the wide adoption of high magnetic field strength 
scanners (3T and some 7T scanners for humans and as high as 15T for mice) has produced more 
reliable results. The increase in reliability from the transition from 1.5T scanners to 3T scanners is 
derived from the increase in signal to noise ratio. While some of the technical downfalls of the 
increasing magnetic field strength scanners are beyond the scope of this paper, it is worth noting 
that increasing magnetic field strength yields sharper images with optimal contrast between white 
and gray matter structures. Because the determination of cortical thickness values from T1-
weighted images relies upon the contrast between gray and white matter structures, it would follow 
that an image constructed with a high magnetic field strength scanner would yield more accurate 
cortical thickness values (Schmitt, 2004). In fact, one study found that the difference between 1.5T 
and 3T field strength changed cortical thickness values by 0.17 mm (Han et al., 2006). Contrary 
to the Fjell (2009) study that successfully consolidated six cohorts using 1.5T scanners, the present 
study likely benefitted from the usage of 3T scanners. This upgrade in magnetic field strength 
likely attenuated the potential for inconsistencies between cortical thickness values. However, the 
effect of the difference of spatial resolution is unclear. The Human Connectome Project utilized a 
Siemens Skyra that was advanced for its time, due to its unusually high spatial resolution as a 
result of a 0.7mm isotropic voxel, which can be compared to the Mayo Clinic Study of Aging’s 
usage of GE scanners, which had a voxel size of 1.20 × 1.015 × 1.015 mm. It is likely that the 
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increased temporal resolution yielded more reliable measures of cortical thickness; though the 
effect has not been quantified. Also of note is the fact that the scanners in each did differ in terms 
of manufacturer. For reasons that are not fully understood, a common confounder of studies using 
MRI analysis content that the manufacturer of scanner has an effect on the corresponding values 
used. One study found that the difference in cortical thickness as a result of the usage of Siemens 
and GE scanners was about 0.15 mm on average (Han et al., 2006). Because Fjell and colleagues 
were able to consolidate multiple cohorts while using scanners of a different manufacturer and the 
fact that the cortical thickness values from this study differed by more than 0.15mm, it is likely 
that the inconsistencies between did not arise due to the usage of different manufactured scanners. 
Instead, it is likely that the inconsistency arises from one or a combination of other factors.  
(iv) Different segmentation procedures 
 
As previously described, the general process by which values of cortical thickness are 
calculated is done by computing the difference between the gray matter and white matter pial 
surfaces within T1-weighted MR images. The high degree of contrast between gray and white 
matter tissue facilitate this computation (Fjell et al., 2009). Segmentation procedures allow for the 
quantification and differentiation of gray and white matter tissue. The usage of different 
segmentation procedures can produce cortical thickness values that can upon “imaging modality, 
the set-up, and the parameters chosen for data recording” (Schick, 2016). Because imaging 
modality, set-ups, and data parameters were largely congruous between the two data sets, there 
exists the possibility that data inconsistencies could have arisen from a step performed prior to 
segmentation, known as spatial normalization. Spatial normalization is the process by which 
brain volumes are scaled versus a standardized template in order for data to be compared across 
individuals in like terms (Crivello et al., 2002).  
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FreeSurfer was the program of choice employed by the Human Connectome Project. It is 
a surface-based segmentation procedure that normalizes data based on a Talaraich alignment, 
which has been previously described in great detail (Fischl et al., 2002 & Fischl et al., 2004).  On 
the other hand, the Mayo Clinic Study of Aging used a combination of SPM12 and the DiReCT 
algorithm to calculate measures of cortical thickness. SPM12 (Statistical Parametric Mapping) is 
a voxel-based morphometry method of tissue segmentation, which “requires the images to be 
spatially normalized, segmented into different tissue classes, and smoothed, prior to performing 
statistical tests (Ashburner & Friston, 2005). The result is a tissue-segmentation map of the cortex 
that can be directly inputted into the algorithm that calculates cortical thickness, DiReCT. In the 
Mayo Clinic Study of Aging, rather than using a standardized tissue normalization structure, such 
as the Talaraich or Montreal Neurological Institute (MNI) atlases, it uses a customized, in-house 
template derived from an elderly individual and adapted to the Tailarach atlas. This modified 
template was used to create a common atlas that was more similar to the population of interest, 
older individuals (Schwartz, 2016).  
Fjell and colleagues (2009) claimed that different segmentation procedures could lead to 
inconsistencies across the combination of multiple cohorts. However, we posit that the 
discrepancies between cortical thickness values from the Human Connectome Project and the 
Mayo Clinic Study of Aging are derived from different spatial normalization procedures, rather 
than different segmentation procedures. Previous studies have reported that cortical thickness 
values derived from FreeSurfer are within a ¼ mm in accuracy to the true histological thickness 
of the brain (Rosas et al., 2002). Given this finding, it is likely that FreeSurfer cortical thickness 
values are accurate representations of true morphology. Additionally, a recent study has found no 
significant differences in reliability between FreeSurfer cortical thickness values and SPM12 + 
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DiReCT values (Schwartz, 2016). As such, it is clear that both methods can accurately determine 
cortical thickness values when a common template is utilized. As such, these cortical thicknesses 
are accurate relative to the index from which these values are derived. If these indices differ, 
discrepancies within the data can arise.  
Typically, differences arising from the usage of different spatial normalization procedures 
can be easily corrected for. For example, it is known that there exist significant differences between 
data derived from Talaraich and MNI atlases. Accordingly, there exist highly effective conversion 
techniques to reduce differences between data (Laird et al., 2010). Because the usage of non-
standardized atlases is rare, there does not exist a method to convert data between atlases. 
Therefore, the effect of using two different Talaraich atlases cannot be quantified. What is clear 
though is that there do exist significant discrepancies between the data that likely did not arise due 
to some of the common confounders suggested by Fjell. Therefore, it is possible that the increased 
cortical thickness values seen in the Mayo Clinic Study of Aging cohort relative to the Human 
Connectome Cohort, could have arisen due to the elderly template which was utilized by the Mayo 
Clinic Study of Aging.  
(v) Sample characteristics 
 
Fjell and colleagues (2009) noted the potential for differences between the six samples as 
a potential confounder for some of their results. In that study, authors raised the possibility of 
confounders arising due to differences in age range between the six samples. The present study 
represents an extreme of that issue. Because the present study sought to understand cortical 
thinning across the lifespan and the fact that no cohort has encapsulated the entire lifespan, it was 
necessary to use two cohorts of which there was no overlap in the age range. Fjell and colleagues 
posited that the difference in age range between the six samples could have contributed to some of 
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the differences in age effects from their analyses. It would then follow that the same issue could 
have arisen due to the two cohorts in this study having different age ranges. Though, one of the 
main objectives of this study was to determine whether different age ranges differed in cortical 
thinning patterns; whereas the Fjell study sought to determine whether the age effect differs 
between a single age range, using multiple samples.  As such, the present study requires differences 
in age range as an independent variable; while Fjell sought to hold age range constant in an attempt 
to understand a different question.  
Additionally, a secondary objective of this study, to investigate the potential effects of 
cardiovascular and metabolic disease profiles to determine its effect on cortical thinning patterns, 
was inappropriate. Such an analysis could have only been completed if the two cohorts differed 
with respect to their disease profiles. As such, it is likely that cortical thickness values differed 
between the two samples as a result of cardiovascular and metabolic diseases, which would 
contribute to differential characteristics between the samples. Similar to the age range, the 
differences in cardiovascular metabolic disease profiles was one essential to the analyses 
performed by this experiment. Besides age and cardiovascular disease, there is the potential that 
the two cohorts differ with respect to level of education. The Mayo Clinic Study of Aging accounts 
for education level within their analyses following literature suggesting the importance of 
education levels and its effect on the phenomenon of cognitive reserve (Vemuri et al., 2011; 
Sundermann et al., 2016). On the other hand, the Human Connectome Project does not account for 
level of education. There exist many discrepancies in the data collected between the Mayo Clinic 
Study of Aging and the Human Connectome Project due to each having different objectives. 
Without the ability to correct, or even be aware of, these differences it is possible that this could 
limit the utility of the present analyses.  
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Rationale for inconsistencies  
 
Taken together, it is unlikely that the differences in the cortical thickness values from the 
Human Connectome Project differed as a result of factors one, three, or five: the statistical analyses 
performed were constant between the data sets, both scanners were highly advanced scanners with 
a large magnetic field strength, and there did not exist significant differences in sample 
characteristics, relevant to the study. On the other hand, it is likely that some discrepancies arose 
from the different segmentation procedures used between the studies which resulted in slightly 
varied meta-ROIs. Perhaps, most importantly, the discrepancies between the two data sets could 
have arisen as a result of the usage of different spatial normalization techniques. While spatial 
normalization is an accepted procedure to create datasets that are not confounded by total 
intracranial volume, the usage of two different atlases, both derived from the Talaraich atlas, likely 
produced the difference in scaling between the data sets.  
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CONCLUSION 
The present study sought to investigate the normal aging process by cross-sectionally 
analyzing cortical thinning patterns across the lifespan using two large cohorts, from the Human 
Connectome Project and the Mayo Clinic Study of Aging. Despite the imperfections seen in the 
cortical thickness values between the two cohorts, generalized linear models were constructed to 
investigate age and sex effects. We found age effects in four out of five composite regions of 
interest (Sensorimotor Cortex, Parietal Lobe, Frontal Lobe, and Cingulate Gyrus) between both 
cohorts. There were additionally sex effects within the Mayo Clinic Study of Aging cohort, but 
not in the Human Connectome Project. Age effects were more significant in older individuals than 
in younger individuals. Taken together, the present study could suggest a critical point after the 
age of 36 wherein sex begins to affect global thinning of the cortex.  
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